Valmo Pharmaceuticals Private Limited
About Valmo Pharmaceuticals Private Limited
Data last updated:
Valmo Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2019PTC123487. Its GSTIN is 29AAGCV8979E1ZJ (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sonal Jain and Kirti Sonegara.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.09 Cr, a growth of 46% compared to the previous year. For the same year it recorded a net profit of ₹54.01 Lakh (net margin 8.9%) and EBITDA of ₹1.04 Cr (EBITDA margin 17%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years.
As per MCA filings, the company has open charges of ₹64.6 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo 2 Royal Tower Ground Floor 3rd Cross Aziz Sait Industrial Estate Nayandahall, I, Bangalore, Karnataka, India – 560039
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Valmo Pharmaceuticals Private Limited
The main business activity of Valmo Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Valmo Pharmaceuticals Private Limited FY 2025 filings available
Valmo Pharmaceuticals Private Limited reported revenue of ₹6.09 Cr (up 46% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Valmo Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 31% over three years, including 46% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Valmo Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.04 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹54.01 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Valmo Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Valmo Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Valmo Pharmaceuticals Private Limited
Valmo Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Copernicium Pharmaceuticals Private Limited | ₹6.15 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Bangalore, Karnataka, India |
| Sanovi Pharmaceuticals Private Limited | ₹6.15 Cr (FY 2024) | •••• | •••• | -22.0% | •••• | Bangalore, Karnataka, India |
| Sacem Pharmaceuticals Private Limited | ₹6.13 Cr (FY 2024) | •••• | •••• | -9.0% | •••• | Ranchi, Jharkhand, India |
| Louis Pharmaceuticals Private Limited | ₹6.13 Cr (FY 2023) | •••• | •••• | 50.0% | •••• | Hyderabad, Telangana, India |
| Little Greave Pharmaceuticals Private Limited | ₹6.1 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Kumedi, Madhya Pradesh, India |
| Valmo Pharmaceuticals Private Limited this company | ₹6.09 Cr (FY 2025) | •••• | •••• | 46.0% | •••• | Bangalore, Karnataka, India |
| Ultra Chiron Pharmaceuticals Pvt Ltd | ₹6.09 Cr (FY 2025) | •••• | •••• | -25.0% | •••• | Chandigarh, India |
| Prowill Pharmaceuticals Private Limited | ₹6.03 Cr (FY 2025) | •••• | •••• | -49.0% | •••• | Navi Mumbai, Maharashtra, India |
| Medvite Pharmaceuticals (OPC) Private Limited | ₹6.02 Cr (FY 2025) | •••• | •••• | 45.0% | •••• | Bengaluru, Karnataka, India |
| Nyx Pharmaceuticals Private Limited | ₹6.02 Cr (FY 2024) | •••• | •••• | 32.0% | •••• | Chandigarh, India |
| Hishimo Pharmaceuticals Private Limited | ₹6.01 Cr (FY 2024) | •••• | •••• | -37.0% | •••• | Jaipur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Valmo Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Valmo Pharmaceuticals Private Limited
Valmo Pharmaceuticals Private Limited is audited by MAHENDRA JAIN & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MAHENDRA JAIN & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Valmo Pharmaceuticals Private Limited
Valmo Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sonal Jain | Director | 16 Apr 2019 | 7 Years 5 Months | Current |
| Kirti Sonegara | Director | 16 Apr 2019 | 7 Years 5 Months | Current |
| Narendrakumar Otmalji | Director | 16 Apr 2019 | 7 Years 5 Months | Current |
Ownership and Shareholding of Valmo Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Valmo Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Aug 2024 | Hdfc Bank Limited | ₹14.6 Lakh | Open |
| 18 Apr 2023 | Others | ₹50 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Valmo Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Valmo Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Valmo Pharmaceuticals Private Limited
Valmo Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Kirti Sonegara was appointed as Director on 16 Apr 2019.
Credit Ratings, Litigation & Regulatory Alerts for Valmo Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Valmo Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Valmo Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Valmo Pharmaceuticals Private Limited
Valmo Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAGCV8979E1ZJ | Karnataka | Active | 21 Jan 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Valmo Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Valmo Pharmaceuticals Private Limited
Valmo Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 April 2019 (7+ years old) and is registered under CIN U24290KA2019PTC123487.
Valmo Pharmaceuticals reported revenue of ₹6.09 Cr for FY 2025 (up 46% YoY).
Valmo Pharmaceuticals has 3 current directors:
- Sonal Jain - Director
- Kirti Sonegara - Director
- Narendrakumar Otmalji - Director
Valmo Pharmaceuticals reported a net profit of ₹54.01 Lakh (net margin 8.9%) and EBITDA of ₹1.04 Cr (EBITDA margin 17%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Valmo Pharmaceuticals is 31% over three years. In the latest year (FY 2025) revenue rose 46%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Valmo Pharmaceuticals is 29AAGCV8979E1ZJ, registered in Karnataka.
The CIN (Corporate Identification Number) of Valmo Pharmaceuticals is U24290KA2019PTC123487. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Valmo Pharmaceuticals was incorporated on 16 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Valmo Pharmaceuticals by revenue are Copernicium Pharmaceuticals Private Limited, Sanovi Pharmaceuticals Private Limited, Sacem Pharmaceuticals Private Limited, Louis Pharmaceuticals Private Limited, Little Greave Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Kirti Sonegara was appointed as Director on 16 Apr 2019. Narendrakumar Otmalji was appointed as Director on 16 Apr 2019. Sonal Jain was appointed as Director on 16 Apr 2019.
The registered office of Valmo Pharmaceuticals is at No 2 Royal Tower Ground Floor 3rd Cross Aziz Sait Industrial Estate Nayandahall, I, Bangalore, Karnataka, India – 560039.